DE69514342D1 - Modifizierte polypeptide mit erhoehter biologischer aktivitaet - Google Patents
Modifizierte polypeptide mit erhoehter biologischer aktivitaetInfo
- Publication number
- DE69514342D1 DE69514342D1 DE69514342T DE69514342T DE69514342D1 DE 69514342 D1 DE69514342 D1 DE 69514342D1 DE 69514342 T DE69514342 T DE 69514342T DE 69514342 T DE69514342 T DE 69514342T DE 69514342 D1 DE69514342 D1 DE 69514342D1
- Authority
- DE
- Germany
- Prior art keywords
- modified polypeptides
- biological activity
- increased biological
- increased
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/505—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/216,259 US5580853A (en) | 1994-03-22 | 1994-03-22 | Modified polypeptides with increased biological activity |
PCT/US1995/003242 WO1995025746A1 (en) | 1994-03-22 | 1995-03-15 | Modified polypeptides with increased biological activity |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69514342D1 true DE69514342D1 (de) | 2000-02-10 |
DE69514342T2 DE69514342T2 (de) | 2000-11-30 |
Family
ID=22806382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69514342T Expired - Fee Related DE69514342T2 (de) | 1994-03-22 | 1995-03-15 | Modifizierte polypeptide mit erhoehter biologischer aktivitaet |
Country Status (9)
Country | Link |
---|---|
US (1) | US5580853A (de) |
EP (1) | EP0751959B1 (de) |
AT (1) | ATE188486T1 (de) |
DE (1) | DE69514342T2 (de) |
DK (1) | DK0751959T3 (de) |
ES (1) | ES2143620T3 (de) |
GR (1) | GR3033146T3 (de) |
PT (1) | PT751959E (de) |
WO (1) | WO1995025746A1 (de) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6153407A (en) * | 1992-07-28 | 2000-11-28 | Beth Israel Deaconess Medical Center | Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics |
US5614184A (en) * | 1992-07-28 | 1997-03-25 | New England Deaconess Hospital | Recombinant human erythropoietin mutants and therapeutic methods employing them |
US5747446A (en) * | 1994-03-22 | 1998-05-05 | Beth Israel Deaconess Medical Center | Modified polypeptides with increased biological activity |
US5919758A (en) * | 1994-03-22 | 1999-07-06 | Beth Israel Deaconess Medical Center | Modified polypeptides with altered biological activity |
US5767078A (en) * | 1995-06-07 | 1998-06-16 | Johnson; Dana L. | Agonist peptide dimers |
AU733212B2 (en) | 1996-03-28 | 2001-05-10 | Board Of Trustees Of The University Of Illinois, The | Material and methods for making improved liposome compositions |
US6242570B1 (en) | 1997-07-10 | 2001-06-05 | Beth Israel Deaconess Medical Center | Production and use of recombinant protein multimers with increased biological activity |
AU8182298A (en) * | 1997-07-10 | 1999-02-08 | Beth Israel Deaconess Medical Center | Recombinant erythropoietin / immunoglobulin fusion proteins |
US6165476A (en) * | 1997-07-10 | 2000-12-26 | Beth Israel Deaconess Medical Center | Fusion proteins with an immunoglobulin hinge region linker |
US6187564B1 (en) | 1997-07-10 | 2001-02-13 | Beth Israel Deaconess Medical Center | DNA encoding erythropoietin multimers having modified 5′ and 3′ sequences and its use to prepare EPO therapeutics |
US6217886B1 (en) | 1997-07-14 | 2001-04-17 | The Board Of Trustees Of The University Of Illinois | Materials and methods for making improved micelle compositions |
US6605648B1 (en) * | 1999-04-06 | 2003-08-12 | Phillips Plastics Corporation | Sinterable structures and method |
US20090175821A1 (en) * | 1999-05-17 | 2009-07-09 | Bridon Dominique P | Modified therapeutic peptides with extended half-lives in vivo |
BR0010750A (pt) * | 1999-05-17 | 2002-02-26 | Conjuchem Inc | Peptìdeos insulinotrópicos de longa duração |
US20040266673A1 (en) * | 2002-07-31 | 2004-12-30 | Peter Bakis | Long lasting natriuretic peptide derivatives |
CA2499211A1 (en) * | 1999-05-17 | 2000-11-23 | Conjuchem Inc. | Modified peptides yy and conjugates thereof |
US6849714B1 (en) * | 1999-05-17 | 2005-02-01 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
US6887470B1 (en) | 1999-09-10 | 2005-05-03 | Conjuchem, Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
US6514500B1 (en) * | 1999-10-15 | 2003-02-04 | Conjuchem, Inc. | Long lasting synthetic glucagon like peptide {GLP-!} |
US7601691B2 (en) * | 1999-05-17 | 2009-10-13 | Conjuchem Biotechnologies Inc. | Anti-obesity agents |
JP4944324B2 (ja) * | 1999-07-13 | 2012-05-30 | ボルダー バイオテクノロジー, インコーポレイテッド | 免疫グロブリン融合タンパク質 |
US6706892B1 (en) * | 1999-09-07 | 2004-03-16 | Conjuchem, Inc. | Pulmonary delivery for bioconjugation |
US6703480B1 (en) | 1999-11-24 | 2004-03-09 | Palani Balu | Peptide dimers as agonists of the erythropoientin (EPO) receptor, and associated methods of synthesis and use |
WO2002024899A2 (en) | 2000-09-25 | 2002-03-28 | Valentis, Inc. | Improved system for regulation of transgene expression |
JP2004520395A (ja) * | 2001-02-02 | 2004-07-08 | コンジュケム,インコーポレーテッド | 長期持続性成長ホルモン放出因子誘導体 |
AU2002233089B2 (en) * | 2001-02-16 | 2005-12-22 | Conjuchem Biotechnologies Inc. | Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders |
ITMI20011986A1 (it) * | 2001-09-25 | 2003-03-25 | San Raffaele Centro Fond | Metodo e composizione per l'attivazione di cellule presentanti l'antigene |
GB0209896D0 (en) * | 2002-04-30 | 2002-06-05 | Molmed Spa | Conjugate |
GB0209893D0 (en) * | 2002-04-30 | 2002-06-05 | Molmed Spa | Conjugate |
AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
ES2343518T3 (es) * | 2002-09-09 | 2010-08-03 | Hanall Biopharma Co., Ltd. | Polipeptidos interferon alfa modificados resistentes a proteasas. |
ATE459647T1 (de) | 2003-04-15 | 2010-03-15 | Glaxosmithkline Llc | Humane il-18 substitutionsmutanten und deren konjugate |
EP1628686A2 (de) * | 2003-05-12 | 2006-03-01 | Affymax, Inc. | Abstandsteil für mit poly (ethylenglycol) modifizierten peptide |
UA88146C2 (ru) * | 2003-05-12 | 2009-09-25 | Афимакс, Инк. | Новые пептиды, которые связываются с рецептором эритропоэтина |
JP2007530440A (ja) * | 2003-05-12 | 2007-11-01 | アフィーマックス・インコーポレイテッド | 新規ポリ(エチレングリコール)修飾化合物およびその用途 |
KR20120094001A (ko) * | 2003-05-12 | 2012-08-23 | 아피맥스, 인크. | 에리스로포이에틴 수용체에 결합하는 펩티드 |
EP2100904B1 (de) | 2004-04-23 | 2010-07-07 | ConjuChem Biotechnologies Inc. | Festphase zur Verwendung in einem Verfahren zur Reinigung von Albuminkonjugaten |
WO2006060148A2 (en) * | 2004-11-11 | 2006-06-08 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
WO2006062685A2 (en) * | 2004-11-11 | 2006-06-15 | Affymax, Inc. | Novel peptides that bind to the erythropoietin receptor |
WO2006063055A2 (en) * | 2004-12-06 | 2006-06-15 | Bolder Biotechnology, Inc. | Enzyme conjugates for use as detoxifying agents |
EP2364995A1 (de) * | 2004-12-23 | 2011-09-14 | Molmed SpA | Konjugatprodukt |
AU2006213662B2 (en) * | 2005-02-11 | 2010-08-05 | Immunogen, Inc. | Process for preparing stable drug conjugates |
US20110166319A1 (en) * | 2005-02-11 | 2011-07-07 | Immunogen, Inc. | Process for preparing purified drug conjugates |
US7550433B2 (en) * | 2005-06-03 | 2009-06-23 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
US7919461B2 (en) | 2005-06-03 | 2011-04-05 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
US8324159B2 (en) * | 2005-06-03 | 2012-12-04 | Affymax, Inc. | Erythropoietin receptor peptide formulations and uses |
EP2399609B1 (de) * | 2005-08-24 | 2015-03-18 | ImmunoGen, Inc. | Verfahren zur Herstellung von Maytansinoid-Antikörper-Konjugaten |
US8039432B2 (en) | 2005-11-09 | 2011-10-18 | Conjuchem, Llc | Method of treatment of diabetes and/or obesity with reduced nausea side effect |
WO2008065372A2 (en) | 2006-11-28 | 2008-06-05 | Nautilus Biotech, S.A. | Modified erythropoietin polypeptides and uses thereof for treatment |
US20090099074A1 (en) * | 2007-01-10 | 2009-04-16 | Conjuchem Biotechnologies Inc. | Modulating food intake |
HUE043645T2 (hu) | 2009-06-03 | 2019-08-28 | Immunogen Inc | Konjugációs módszerek |
PT2691155T (pt) | 2011-03-29 | 2019-02-19 | Immunogen Inc | Preparação de conjugados de anticorpo de maitansinoide por processo de uma etapa |
EP2742064B1 (de) | 2011-08-09 | 2016-07-27 | UAB Profarma | Derivate aus rekombinanten proteinen, homo-multimere des granulozyten-kolonie-stimulierenden faktors und verfahren zu ihrer herstellung |
CA2886993A1 (en) | 2012-10-04 | 2014-04-10 | Immunogen, Inc. | Use of a pvdf membrane to purify cell-binding agent cytotoxic agent conjugates |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4258193A (en) * | 1978-07-13 | 1981-03-24 | Toyo Jozo Kabushiki Kaisha | Disulfide derivatives having S--S exchange reactivity |
US4659839A (en) * | 1984-10-10 | 1987-04-21 | Mallinckrodt, Inc. | Coupling agents for radiolabeled antibody fragments |
US4677195A (en) * | 1985-01-11 | 1987-06-30 | Genetics Institute, Inc. | Method for the purification of erythropoietin and erythropoietin compositions |
US4797491A (en) * | 1986-03-17 | 1989-01-10 | Cetus Corporation | Compound 1-(3-(2-pyridyldithio)propionamido)-12-(5-hydrazidoglutaramido)-4,9-dioxadodecane |
US5260421A (en) * | 1987-12-21 | 1993-11-09 | Applied Research Systems Ars Holding N.V. | Site-directed mutagenesis modified glycoprotein hormones |
US4904584A (en) * | 1987-12-23 | 1990-02-27 | Genetics Institute, Inc. | Site-specific homogeneous modification of polypeptides |
US5066490A (en) * | 1988-06-01 | 1991-11-19 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Protein crosslinking reagents cleavable within acidified intracellular vesicles |
US5241078A (en) * | 1988-06-14 | 1993-08-31 | Cetus Oncology | Coupling agents and sterically hindered disulfide linked conjugates prepared therefrom |
US5024834A (en) * | 1988-07-12 | 1991-06-18 | Cetus Corporation | Thioether linked immunotoxin conjugates |
US5112615A (en) * | 1988-08-03 | 1992-05-12 | New England Deaconess Hospital Corporation | Soluble hirudin conjugates |
US5134071A (en) * | 1989-02-06 | 1992-07-28 | State University Of New York | Polymerization and copolymerization of proteins |
US5157123A (en) * | 1989-03-13 | 1992-10-20 | Georgetown University | S-(2-thiopyridyl)-l-cysteine, a heterobifunctional crosslinking reagent |
US5116944A (en) * | 1989-12-29 | 1992-05-26 | Neorx Corporation | Conjugates having improved characteristics for in vivo administration |
-
1994
- 1994-03-22 US US08/216,259 patent/US5580853A/en not_active Expired - Lifetime
-
1995
- 1995-03-15 DK DK95912917T patent/DK0751959T3/da active
- 1995-03-15 WO PCT/US1995/003242 patent/WO1995025746A1/en active Search and Examination
- 1995-03-15 PT PT95912917T patent/PT751959E/pt unknown
- 1995-03-15 EP EP95912917A patent/EP0751959B1/de not_active Expired - Lifetime
- 1995-03-15 DE DE69514342T patent/DE69514342T2/de not_active Expired - Fee Related
- 1995-03-15 ES ES95912917T patent/ES2143620T3/es not_active Expired - Lifetime
- 1995-03-15 AT AT95912917T patent/ATE188486T1/de not_active IP Right Cessation
-
2000
- 2000-04-04 GR GR20000400839T patent/GR3033146T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GR3033146T3 (en) | 2000-08-31 |
ATE188486T1 (de) | 2000-01-15 |
ES2143620T3 (es) | 2000-05-16 |
DE69514342T2 (de) | 2000-11-30 |
US5580853A (en) | 1996-12-03 |
PT751959E (pt) | 2000-06-30 |
EP0751959B1 (de) | 2000-01-05 |
WO1995025746A1 (en) | 1995-09-28 |
DK0751959T3 (da) | 2000-06-26 |
EP0751959A1 (de) | 1997-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69514342D1 (de) | Modifizierte polypeptide mit erhoehter biologischer aktivitaet | |
IT8619338A0 (it) | Peptide sintetico ad attivita'interleukina 1 umana. | |
IT8812558A0 (it) | Poltrona per abbronzatura | |
DE3582183D1 (de) | Dns den menschlichen tumornekrosisfaktor kodierend und das menschliche tumornekronisfaktor-polypeptid. | |
DK14890A (da) | Peptider med t-hjaelpercelleaktivitet | |
ES8500325A1 (es) | Procedimiento para la preparacion de proteinas funcionales de uroquinasa humana. | |
DE3882593T2 (de) | Polypeptid und dessen Herstellung. | |
DK267885A (da) | Maebel, saasom sidde- eller liggemaebel | |
DK96787A (da) | Human vaevs-plasminogenaktivator | |
DE58902290D1 (de) | Sauerstoffabsorptionsmittel und verwendung desselben. | |
ES2177625T3 (es) | Citoquina cc-1 humana circulante. | |
DK50987D0 (da) | Polypeptid med plasminogenaktivatorvirkning | |
DE3886517D1 (de) | Menschlicher Prourokinase ähnliches Polypeptid. | |
DE3853743D1 (de) | Rekombinanter menschlicher ADF. | |
DE69012958D1 (de) | Fibrinolytisches Protein und Herstellungsweise dafür. | |
DE59003265D1 (de) | Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica. | |
KR890015933U (ko) | 회전의자 | |
DK527287A (da) | Polypeptid med interleukin-2-aktiviteter | |
DE68924022D1 (de) | Protein mit hemmender Aktivität gegenüber menschlichem Plasmin. | |
DE3782199D1 (de) | Biologisch aktive peptide tan-866. | |
DE69019581T2 (de) | Polypeptid und dieses enthaltende antibaktierelle Präparate. | |
IT8619477A0 (it) | Sostanza ad attivita'nootropa e psicostimolante. | |
NO880831D0 (no) | Rekombinant human vevsplasminogen-aktivatorblanding. | |
KR850007051U (ko) | 요동식 침대의자 | |
KR880014653U (ko) | 회전 의자 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: BETH ISRAEL DEACONESS MEDICAL CENTER, INC., BOSTON |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |